semaglutide 2 mg/ml dosing Dosage Chart for Weight Loss and Type Diabetes Ozempic® Pen Dosing | Ozempic®

Two weeks ago the results from PIONEER 6, a cardiovascular outcomes trial examining the safety of oral semaglutide versus placebo, were published in the prestigious New England Journal of Medicine (NEJM) concurrently with being presented at the annual American Diabetes Association conference in San Francisco

The best results happen when the medicine is used along with healthy eating and exercise, and people may gain weight back if they stop taking the medicine

The boring, slow, expensive infrastructure of behavioral neuroscience

Through the Medicare GLP-1 Bridge, eligible beneficiaries can access certain GLP-1 medications for weight management for just a $50...

The Phase 3 ATTAIN-1 trial had good results that led to this approval, but not all positive: 12.4% average weight loss (27.3 lbs) at highest dose Lower than the 15-20% weight loss seen with injectables Wegovy and Zepbound Nearly 1/4 of participants on the highest dose reported vomiting Vomiting rates are much higher than injectable GLP-1s However, there is likely a niche for Foundayo (along with the pill version of Wegovy) due to convenience: No refrigeration requirements or injection site reactions Eliminates barriers for patients avoiding injectables due to stigma, needle aversion, or storage constraints It's possible we could see this as a "maintenance" therapy after an initial injectable course